CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER Dahkki E. N. Imyanitov, T. Yu. Semiglazova

Viečča ollesdeavstta

PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER Dahkki N. A. Kozyavin, T. Yu. Semiglazova

Viečča ollesdeavstta

Clinical end pharmacoeconomic aspects of neoadjuvant therapy of breast cancer Dahkki V. A. Kostorov, T. Yu. Semiglazova, A. V. Pavlysh

Viečča ollesdeavstta

DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST Dahkki T. Yu. Semiglazova, G. M. Teletaeva, N. A. Kozyavin, A. V. Zagatina

Viečča ollesdeavstta

The role of gut microbiota in forming a response to immunotherapy of malignant neoplasms: problem state Dahkki T. Yu. Semiglazova, N. A. Brish, T. Yu. Galunova, A. S. Bernatskiy, V. V. Semiglazov

Viečča ollesdeavstta

Problems of diagnostics and treatment of the epithelial and non-epithelial breast tumors Dahkki Van Shu, A. S. Artemieva, E. A. Busco, V. V. Semiglazov, T. Yu. Semiglazova

Viečča ollesdeavstta

The state of cancer care in Russia: breast cancer. Epidemiology and survival of patients. The impact of the SARS-CoV-2-beta-coronavirus epidemic (clinical and population study) Dahkki V. M. Merabishvili, V. F. Semiglazov, A. V. Komiakhov, T. Yu. Semiglazova, P. V. Krivorotko, А. M. Belyaev

Viečča ollesdeavstta

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer Dahkki T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov

Viečča ollesdeavstta

Features of nutritional support during stem cell transplantation Dahkki S. A. Volchenkov, L. V. Filatova, E. V. Cherkasova, A. K. Koviazin, S. V. Lyubimov, I. S. Zyuzgin, T. Yu. Semiglazova

Viečča ollesdeavstta

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists) Dahkki V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev

Viečča ollesdeavstta

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment Dahkki V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov

Viečča ollesdeavstta

International rehabilitation model for oncological patients Dahkki T. Yu. Semiglazova, V. A. Klyuge, B. S. Kasparov, K. O. Kondratyeva, A. A. Krutov, M. A. Zernova, V. A. Chulkova, V. V. Semiglazov

Viečča ollesdeavstta

2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol): blood content in rats after intravenous administration and chemical resistance Dahkki V. A. Alexandrov, G. V. Tochilnikov, S. V. Shatik, A. N. Stukov, O. A. Beljaeva, E. V. Bashkatova, V. G. Dranishnikov, T. Yu. Semiglazova

Viečča ollesdeavstta

Activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propandyоl (chlonisol) versus lomustine in intracranial transplanted tumor model in mice Dahkki Yu. G. Zmitrichenko, A. N. Stukov, V. А. Aleksandrov, G. V. Tochilnikov, I. G. Murazov, D. Н. Latipova, L. V. Filatova, T. Yu. Semiglazova

Viečča ollesdeavstta

The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma Dahkki Aleksei K. Koviazin, Larisa V. Filatova, Ilia S. Zyuzgin, Anna S. Artemyeva, Ilia L. Poliatskin, Darya S. Burda, Stanislav A. Volchenkov, Svetlana S. Elkhova, Tatiana Yu. Semiglazova

Viečča ollesdeavstta

Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) in C57BL/6 mice with intracranially transplanted B16 melanoma Dahkki I. G. Murazov, A. N. Stukov, Iu. G. Zmitrichenko, A. O. Niuganen, G. V. Tochilnikov, D. Ch. Latipova, L. V. Filatova, T. Yu. Semiglazova

Viečča ollesdeavstta

Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer Dahkki R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova

Viečča ollesdeavstta

Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction Dahkki A. I. Stukan, V. N. Bodnya, V. A. Porkhanov, T. Yu. Semiglazova, O. Yu. Chukhray, E. A. Nefedova, O. N. Nefedov, D. V. Xenodokhov, S. D. Maksimenko

Viečča ollesdeavstta

Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma Dahkki E. V. Kharchenko, T. Yu. Semiglazova, A. S. Artem’yeva, G. S. Kireyeva, I. L. Polyatskin, I. S. Zyuzgin, L. V. Filatova, Yu. A. Chudinovskikh, M. S. Motalkina, Yu. A. Oleynik

Viečča ollesdeavstta

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe... Dahkki E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov

Viečča ollesdeavstta